INDEPENDENT THINKING. BETTER EVIDENCE.WEIGHT, HEALTH & THE SCIENCE BETWEEN
News

Retatrutide TRIUMPH-2: why 18.8% and 20.8% both appear

The September 2026 trial adds evidence in type 2 diabetes, with two distinct weight-loss analyses and US approval still absent.

Editorial evidence review ·
Two folded blank paper ribbons beside three translucent glass prisms on a pale surface.
Conceptual editorial illustration for MyWeightLab. It does not depict a medicinal product, measured trial result or treatment recommendation.

Evidence and fact-checking standards · Report a correction

Cookie policy